WHAT: This journal club meeting will discuss information on hemp-derived cannabinoids from two published studies.
WHEN: The First Tuesday of Every Month
Tuesday April 2nd (Tomorrow)
8pmEST- 845pm EST
Link:https://us02web.zoom.us/s/83722922366?pwd=QjZ3V0xNWHZ0OVZ0b3BpbWd3STRqUT09#success
Who Should Attend: This event is essential for doctors and healthcare professionals keen on staying abreast of the latest public health issues related to hemp, cannabis, and cannabinoids.
Special Features:
- Expert-led Presentation on Recent Scientific Publications
- Interactive Q&A and Discussion Sessions
- Updates on Current Research Projects and Data Collection Programs
- Content and Resources for the Discussion
D8-THC Adverse Event Reporting: https://drive.google.com/file/d/1S9vz-dhtDBbr4s8VowogKBNJNLrKguLz/view?usp=sharing
JAMA 2022 Hemp Loophole Commentary: https://drive.google.com/file/d/1K1qs8T__jR4HRyTOnkuAYrjNqTV3fz6w/view
Discussion Highlights:
- Review of Recent Studies: We will examine recent research findings that help interpret and think critically about public health data related to cannabinoids.
- Preventive Strategies and Public Health Policies: We will discuss potential strategies and interventions to mitigate risks associated with hemp-derived cannabinoids, including public education campaigns, policy recommendations, and clinical guidelines.
Objectives:
- To critically assess the latest evidence on the public health impact of hemp cannabinoids.
- To understand the complexities surrounding this issue.
- To evaluate the implications for public health, policy-making, and clinical practice in light of current research.
- For additional information, please visit: https://www.prc-trials-plus.com/live-sessions/journal-club-duic-and-impairment-gr4s3
